Form 4 for UPXI UPEXI, INC.
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-11 · accession 0001477932-25-005338 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-07-30 | 2025-07-16 | UPXI | Salkind Gene | Dir, 10% | A - Grant | $0.00 | +200.0K | 435.4K | +85% | $0 |
| 2025-07-30 | 2025-07-11 | UPXI | Salkind Gene | Dir, 10% | P - Purchase | $4.94 | +20.2K | 385.4K | +6% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-16 | A | A | 150,000 | $0.00 | 585,370 | D | — | — | (F3) Vests quarterly in equal installments over 12 months beginning July 1, 2025. (F4) The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. |
| 2 | Common | Common Stock | 2025-07-16 | A | A | 50,000 | $0.00 | 435,370 | D | — | — | (F4) The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan. (F2) Vests in full 90 days from July 1, 2025. |
| 3 | Common | Common Stock | 2025-07-11 | P | A | 20,243 | $4.94 | 385,370 | D | — | — | (F1) The Reporting Person purchased these shares pursuant to a private placement offering conducted by the Issuer. The Common Stock is being offered pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws. |